Development

Patricia Van Arnum was executive editor of Pharmaceutical Technology.

Articles

Jim Miller, president of PharmSource, examines the future direction of CROs/CMOs and the factors influencing the pharmaceutical contract services sectors.

A Look into the Future of Pharmaceutical Outsourcing: Perspectives from Jim Miller, president of PharmSource

Gregg Brandyberry is senior vice-president of FedBid, and formerly senior advisor for A.T. Kearney Procurement and Analytic Solutions, Gregg.Brandyberry@FedBid.com

The past three decades have driven a purchasing evolution to a procurement revolution.

Reflecting on 35 Years of Procurement Transformation

Tracking changes from spinoffs of chemical companies to life-sciences powerhouses.

35th Anniversary Special: Decades of Change for the Top Pharmaceutical Companies

Companies roll out expansions in manufacturing high-potency APIs and finished products.

High-Potency Manufacturing Remains Strong

Sponsor companies' increasing focus on strategic outsourcing has changed the rules of the game.

35th Anniversary Special: New Models in Contract Services

Flow chemistry and microreactors offer alternatives to traditional batch manufacturing.

35th Anniversary Special: What's Ahead in Chemical API Manufacturing

Peptides and related technologies to are starting to improve production.

Peptides Gain Traction in Drug Development

Eric Langer has over 25 years experience in biotechnology and life sciences strategic marketing management, market research, and publishing. He has held senior management and marketing positions at biopharmaceutical supply companies. He has published and authored many books and reports on topics in Biotechnology, Large-scale BioManufacturing, and bioscience commercialization and communication. He teaches at Johns Hopkins University marketing management, biotech marketing, services marketing, and marketing in a regulated environment. In 1989 he co-founded BioPlan Associates, Inc. to provide market analysis, and strategy to biotech and healthcare organizations.

Industry wants more innovation, but can suppliers meet customer needs?

Biomanufacturing Innovation

Partnerships between industry and academic medical centers are expanding to meet R&D needs.

Innovation Boom Towns

Targeted polymeric nanoparticles are an important vehicle for controlling and targeting dosing of chemotherapeutic agents.

Ingredients